ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
124.031,14
-0,80%
S&P 500
5.687,35
-1,44%
US Dollar vs BRL
5,7945
0,11%
Bitcoin
82.341,19
2,18%
Brent Oil
69,86
0,19%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Nautilus Biotechnology Inc (NAUT)

  7. Nautilus Biotechnology Inc (NAUT) Notícias

NAUT

Nautilus Biotechnology (NAUT)

Nautilus Biotechnology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NAUT
DataHoraFonteTítuloCódigoCompanhia
05/03/202518:57Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:NAUTNautilus Biotechnology Inc
04/03/202518:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
27/02/202518:52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NAUTNautilus Biotechnology Inc
27/02/202518:46Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NAUTNautilus Biotechnology Inc
27/02/202510:00GlobeNewswire Inc.Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
18/02/202510:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
06/02/202510:00GlobeNewswire Inc.Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025NASDAQ:NAUTNautilus Biotechnology Inc
31/01/202519:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAUTNautilus Biotechnology Inc
31/10/202409:00GlobeNewswire Inc.Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator AwardNASDAQ:NAUTNautilus Biotechnology Inc
30/10/202409:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
29/10/202417:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAUTNautilus Biotechnology Inc
29/10/202409:00GlobeNewswire Inc.Nautilus Biotechnology Reports Third Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
08/10/202409:00GlobeNewswire Inc.Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024NASDAQ:NAUTNautilus Biotechnology Inc
17/09/202417:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
17/09/202409:00GlobeNewswire Inc.Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing OfficerNASDAQ:NAUTNautilus Biotechnology Inc
14/08/202409:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
30/07/202409:00GlobeNewswire Inc.Nautilus Biotechnology Reports Second Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
09/07/202409:00GlobeNewswire Inc.Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024NASDAQ:NAUTNautilus Biotechnology Inc
23/05/202409:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
30/04/202409:00GlobeNewswire Inc.Nautilus Biotechnology Reports First Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/04/202409:00GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NAUTNautilus Biotechnology Inc
07/03/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAUTNautilus Biotechnology Inc
06/03/202418:39Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NAUTNautilus Biotechnology Inc
28/02/202410:00GlobeNewswire Inc.Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202409:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAUTNautilus Biotechnology Inc
22/02/202410:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
07/02/202410:00GlobeNewswire Inc.Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:NAUTNautilus Biotechnology Inc
30/11/202310:00GlobeNewswire Inc.Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics AwardNASDAQ:NAUTNautilus Biotechnology Inc
01/11/202309:05GlobeNewswire Inc.Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell DevelopmentNASDAQ:NAUTNautilus Biotechnology Inc
31/10/202309:05GlobeNewswire Inc.Nautilus Biotechnology Reports Third Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NAUT

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
FICT3
Fictor Alimentos ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
RNEW4
RENOVA PN
BOV
PDGR3
PDG REALT ON
BOV
AZEV4
AZEVEDO PN
BOV
TELB4
TELEBRAS PN
BOV
DASA3
DASA ON
BOV
RCSL4
RECRUSUL PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios